Elizabeth Bertone-Johnson to Breast Neoplasms
This is a "connection" page, showing publications Elizabeth Bertone-Johnson has written about Breast Neoplasms.
Connection Strength
1.339
-
Bertone-Johnson ER, McTiernan A, Thomson CA, Wactawski-Wende J, Aragaki AK, Rohan TE, Vitolins MZ, Tamimi RM, Johnson KC, Lane D, Rexrode KM, Peck JD, Chlebowski RT, Sarto G, Manson JE. Vitamin D and calcium supplementation and one-year change in mammographic density in the women's health initiative calcium and vitamin D trial. Cancer Epidemiol Biomarkers Prev. 2012 Mar; 21(3):462-73.
Score: 0.211
-
Bertone-Johnson ER, Chlebowski RT, Manson JE, Wactawski-Wende J, Aragaki AK, Tamimi RM, Rexrode KM, Thomson CA, Rohan TE, Peck JD, Pisano ED, Martin CF, Sarto G, McTiernan A. Dietary vitamin D and calcium intake and mammographic density in postmenopausal women. Menopause. 2010 Nov-Dec; 17(6):1152-60.
Score: 0.194
-
Bertone-Johnson ER. Vitamin D and breast cancer. Ann Epidemiol. 2009 Jul; 19(7):462-7.
Score: 0.173
-
Bertone-Johnson ER. Prospective studies of dietary vitamin D and breast cancer: more questions raised than answered. Nutr Rev. 2007 Oct; 65(10):459-66.
Score: 0.157
-
Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC, Hankinson SE. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2005 Aug; 14(8):1991-7.
Score: 0.135
-
Grimes NP, Bertone-Johnson ER, Whitcomb BW, Sievert LL, Crawford SL, Gold EB, Avis NE, Greendale GA, Santoro N, Habel LA, Reeves KW. Anti-M?llerian hormone levels and breast cancer risk in the study of women's health across the nation. Cancer Causes Control. 2022 Aug; 33(8):1039-1046.
Score: 0.109
-
Holder EX, Houghton SC, Sanchez SS, Eliassen AH, Qian J, Bertone-Johnson ER, Liu Z, Tworoger SS, Smith MT, Hankinson SE. Estrogenic Activity and Risk of Invasive Breast Cancer Among Postmenopausal Women in the Nurses' Health Study. Cancer Epidemiol Biomarkers Prev. 2022 04 01; 31(4):831-838.
Score: 0.107
-
Clendenen TV, Ge W, Koenig KL, Afanasyeva Y, Agnoli C, Bertone-Johnson E, Brinton LA, Darvishian F, Dorgan JF, Eliassen AH, Falk RT, Hallmans G, Hankinson SE, Hoffman-Bolton J, Key TJ, Krogh V, Nichols HB, Sandler DP, Schoemaker MJ, Sluss PM, Sund M, Swerdlow AJ, Visvanathan K, Liu M, Zeleniuch-Jacquotte A. Breast Cancer Risk Factors and Circulating Anti-M?llerian Hormone Concentration in Healthy Premenopausal Women. J Clin Endocrinol Metab. 2021 10 21; 106(11):e4542-e4553.
Score: 0.104
-
Bauer SR, Hankinson SE, Bertone-Johnson ER, Ding EL. Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies. Medicine (Baltimore). 2013 May; 92(3):123-131.
Score: 0.058
-
Green AK, Hankinson SE, Bertone-Johnson ER, Tamimi RM. Mammographic density, plasma vitamin D levels and risk of breast cancer in postmenopausal women. Int J Cancer. 2010 Aug 01; 127(3):667-74.
Score: 0.048
-
Chen WY, Bertone-Johnson ER, Hunter DJ, Willett WC, Hankinson SE. Associations between polymorphisms in the vitamin D receptor and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2005 Oct; 14(10):2335-9.
Score: 0.034
-
Missmer SA, Spiegelman D, Bertone-Johnson ER, Barbieri RL, Pollak MN, Hankinson SE. Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Cancer Epidemiol Biomarkers Prev. 2006 May; 15(5):972-8.
Score: 0.009